广东省佛山市新增5家指定医疗机构 “港澳药械通”政策落地实效进一步提升

Core Insights - The Guangdong Provincial Health Commission and the Guangdong Provincial Drug Administration have announced the fourth batch of designated medical institutions for the "Hong Kong-Macao Drug and Medical Device Pass" in the Guangdong-Hong Kong-Macao Greater Bay Area, adding 27 new institutions, including 5 in Foshan [1] Group 1 - The newly added institutions in Foshan include Foshan First People's Hospital, Southern Medical University Eighth Affiliated Hospital, Nanhai District People's Hospital, Guangdong Provincial People's Hospital Nanhai Hospital, and He You Zhi Zhen Hospital, bringing the total to 6 designated institutions in Foshan [1] - The "Hong Kong-Macao Drug and Medical Device Pass" policy aims to facilitate the use of internationally advanced drugs and medical devices in designated medical institutions within the Greater Bay Area, enhancing the quality of the pharmaceutical industry in Foshan [1] - This policy is a significant innovation supported by the state to promote the construction of the Greater Bay Area, allowing the use of urgently needed drugs and medical devices registered in Hong Kong and Macao in qualified medical institutions in mainland China [1] Group 2 - The Foshan Market Supervision Administration will strengthen guidance and management of the designated medical institutions, focusing on the procurement, acceptance, storage, management systems, emergency response, and risk prevention related to Hong Kong-Macao drugs and medical devices [2] - Institutions are required to establish a comprehensive management system covering application, procurement, storage, usage, traceability, and risk control to ensure drug and device sources are traceable, their destinations are known, risks are controllable, and responsibilities are accountable [2]